Rejoinder Strategy After Allergan Double-Patenting Case

The U.S. Court of Appeals for the Federal Circuit's decision last year in Allergan USA Inc. v. MSN Laboratories Private Ltd. highlights the importance of rejoinder during patent prosecution in view...

Already a subscriber? Click here to view full article